Changqing Xu1, Sijie Tan1, Jiaqiang Zhang2, Christoph N Seubert1, Nikolaus Gravenstein3, Colin Sumners4, Terrie Vasilopoulos1, Anatoly E Martynyuk5. 1. Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL, USA. 2. Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL, USA; Department of Anesthesiology, People's Hospital of Zhengzhou University, Zhengzhou, P.R.China. 3. Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL, USA; The McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA. 4. The McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA; Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, FL, USA. 5. Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL, USA; The McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA. Electronic address: amartynyuk@anest.ufl.edu.
Abstract
BACKGROUND: 1.5 million children under 12 months of age are exposed to general anesthesia annually in the United States alone. Human and especially animal studies provide evidence that exposure to general anesthesia during the early postnatal period may lead to long-term neurocognitive abnormalities via poorly understood mechanisms. We investigated whether an immature stress response system and γ-aminobutyric acid (GABA) type A receptor activities are involved in mediating these abnormalities. METHODS: Sprague-Dawley rats at postnatal days 4, 5 or 6 were anesthetized with 2.1% sevoflurane for 6h; maternally separated and house reared rats served as controls. RESULTS: Sevoflurane anesthesia markedly increased corticosterone levels in rat pups of both genders. In adulthood, these rats responded to stress with heightened secretion of corticosterone and a greater increase in corticosterone levels in males versus females. Only male rats, previously exposed to neonatal sevoflurane, had a higher frequency of miniature inhibitory postsynaptic currents in CA1 neurons, spent a shorter time in open arms of the elevated plus maze (EPM) and exhibited impaired prepulse inhibition (PPI) of startle. Pretreatment of male rats prior to sevoflurane with the Na(+)-K(+)-2Cl(-) cotransporter inhibitor, bumetanide, or the mineralocorticoid receptor antagonist, RU28318, normalized endocrine responses to stress and the EPM behavior in adulthood, while only those pretreated with bumetanide exhibited normalized PPI of startle responses. Neither bumetanide nor RU28318 altered the effect of sevoflurane on synaptic activity. CONCLUSIONS: Sevoflurane-enhanced neuronal excitation and elevated corticosteroid levels at the time of anesthesia contribute to the mechanisms initiating neonatal sevoflurane-induced long-term endocrine and neurobehavioral abnormalities.
BACKGROUND: 1.5 million children under 12 months of age are exposed to general anesthesia annually in the United States alone. Human and especially animal studies provide evidence that exposure to general anesthesia during the early postnatal period may lead to long-term neurocognitive abnormalities via poorly understood mechanisms. We investigated whether an immature stress response system and γ-aminobutyric acid (GABA) type A receptor activities are involved in mediating these abnormalities. METHODS:Sprague-Dawley rats at postnatal days 4, 5 or 6 were anesthetized with 2.1% sevoflurane for 6h; maternally separated and house reared rats served as controls. RESULTS:Sevoflurane anesthesia markedly increased corticosterone levels in rat pups of both genders. In adulthood, these rats responded to stress with heightened secretion of corticosterone and a greater increase in corticosterone levels in males versus females. Only male rats, previously exposed to neonatal sevoflurane, had a higher frequency of miniature inhibitory postsynaptic currents in CA1 neurons, spent a shorter time in open arms of the elevated plus maze (EPM) and exhibited impaired prepulse inhibition (PPI) of startle. Pretreatment of male rats prior to sevoflurane with the Na(+)-K(+)-2Cl(-) cotransporter inhibitor, bumetanide, or the mineralocorticoid receptor antagonist, RU28318, normalized endocrine responses to stress and the EPM behavior in adulthood, while only those pretreated with bumetanide exhibited normalized PPI of startle responses. Neither bumetanide nor RU28318 altered the effect of sevoflurane on synaptic activity. CONCLUSIONS:Sevoflurane-enhanced neuronal excitation and elevated corticosteroid levels at the time of anesthesia contribute to the mechanisms initiating neonatal sevoflurane-induced long-term endocrine and neurobehavioral abnormalities.
Authors: Kristen L Brunson; Enikö Kramár; Bin Lin; Yuncai Chen; Laura Lee Colgin; Theodore K Yanagihara; Gary Lynch; Tallie Z Baram Journal: J Neurosci Date: 2005-10-12 Impact factor: 6.167
Authors: Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff Journal: Psychopharmacology (Berl) Date: 2008-06-21 Impact factor: 4.530
Authors: Ling-Sha Ju; Jiao-Jiao Yang; Ning Xu; Jia Li; Timothy E Morey; Nikolaus Gravenstein; Christoph N Seubert; Barry Setlow; Anatoly E Martynyuk Journal: Anesthesiology Date: 2019-11 Impact factor: 7.892
Authors: L-S Ju; J-J Yang; T E Morey; N Gravenstein; C N Seubert; J L Resnick; J-Q Zhang; A E Martynyuk Journal: Br J Anaesth Date: 2018-06-05 Impact factor: 9.166